ciprofloxacin has been researched along with rifamycin sv in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 7 (87.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| De Pità, O; Giani, M; Guerra, EC; Pirrotta, L; Puddu, P; Scala, E | 1 |
| Arslan, O; Kockar, F; Sinan, S; Yildirim, H | 1 |
| Abdiche, G; Batellier, L; Borsali, E; Chaumeil, C; Gleize, D; Goldschmdt, P; Laroche, L; Le Bouter, A; Legrand, P | 1 |
| Araujo, P; DuPont, HL; Gracias Garcia, ML; Greinwald, R; Jiang, ZD; Nacak, T; Steffen, R; Stiess, M | 1 |
| Connor, P; Riddle, MS; Tribble, DR | 1 |
| Connor, BA; Ericsson, CD; Riddle, MS | 1 |
| DuPont, HL; Steffen, R | 1 |
1 trial(s) available for ciprofloxacin and rifamycin sv
| Article | Year |
|---|---|
Rifamycin SV-MMX® for treatment of travellers' diarrhea: equally effective as ciprofloxacin and not associated with the acquisition of multi-drug resistant bacteria.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Ciprofloxacin; Diarrhea; Drug Resistance, Multiple, Bacterial; Ecuador; Enterotoxigenic Escherichia coli; Escherichia coli Infections; Female; Guatemala; Humans; India; Male; Microbial Sensitivity Tests; Middle Aged; Rifamycins; Travel; Treatment Outcome | 2018 |
7 other study(ies) available for ciprofloxacin and rifamycin sv
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multiple drug allergy syndrome: severe anaphylactic reaction due to topical rifamycin SV in a patient with hypersensitivity to ciprofloxacin.
Topics: Anaphylaxis; Anti-Bacterial Agents; Anti-Infective Agents; Antirheumatic Agents; Ciprofloxacin; Drug Hypersensitivity; Humans; Male; Middle Aged; Rifamycins | 2001 |
Differential effects of some antibiotics on paraoxonase enzyme activity on human hepatoma cells (HepG2) in vitro.
Topics: Ampicillin; Anti-Bacterial Agents; Aryldialkylphosphatase; Ciprofloxacin; Clindamycin; Hep G2 Cells; Hepatocytes; Humans; Kinetics; Osmolar Concentration; Rifamycins | 2010 |
[Ornithinimicrobium pekingense ocular infection].
Topics: Actinomycetales; Actinomycetales Infections; Aged; Cataract; Ciprofloxacin; Corneal Edema; Corneal Ulcer; Drug Resistance, Multiple, Bacterial; Female; Fusidic Acid; Humans; Keratoplasty, Penetrating; Ointments; Ophthalmic Solutions; Postoperative Complications; Rifamycins; Tobramycin | 2011 |
Antibiotics for Travellers' Diarrhoea on Trial-is there a potential role for Rifamycin SV?
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Diarrhea; Humans; Rifamycins; Travel | 2019 |
When should travel medicine practitioners prescribe Rifamycin SV-MXX for self-treatment of travellers' diarrhoea?
Topics: Bacteria; Ciprofloxacin; Diarrhea; Humans; Rifamycins; Travel; Travel Medicine | 2019 |
Rifamycin SV-MMX® as the recommended self-treatment for moderate to severe travellers' diarrhoea: reply.
Topics: Bacteria; Ciprofloxacin; Diarrhea; Humans; Rifamycins; Travel | 2019 |